May 13 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2024 Mar 31, 2023 Dec 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 104 mln 90 mln 400 mln
(+16.5 pct) (-18.0 pct) (-6.6 pct)
Operating loss 318 mln loss 101 mln loss 1.50
Recurring loss 320 mln loss 101 mln loss 1.51
Net loss 320 mln loss 97 mln loss 1.51
EPS loss 9.99 yen loss 3.14 yen loss 47.00 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T